Forma Therapeutics Holdings, Inc., | Business Contracts

Agreement and Plan of Merger, dated as of August 31, 2022, by and among Novo Nordisk A/S, NNUS New Dev, Inc. and Forma Therapeutics Holdings, Inc (Filed With SEC on September 1, 2022)

Amended and Restated Non-Employee Director Compensation Policy (Filed With SEC on August 5, 2022)

Lease Agreement by and between ARE-MA Region No. 75, LLC, and the Registrant, dated as of November 23, 2021 (Filed With SEC on March 1, 2022)

Description of the Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934, as amended (Filed With SEC on March 30, 2021)

Form of Underwriting Agreement (Filed With SEC on December 8, 2020)

Form of Indemnification Agreement between the Registrant and each of its directors and executive officers (Filed With SEC on June 15, 2020)

License Agreement, by and among the Registrant, Forma Therapeutics, Inc. and Celgene Alpine Investment Company II, LLC, dated December 28, 2018 (Filed With SEC on May 29, 2020)

FORMA THERAPEUTICS HOLDINGS, INC. AMENDED AND RESTATED NON-EMPLOYEE DIRECTOR COMPENSATION POLICY (Filed With SEC on March 1, 2022)

Non-Employee Director Compensation Policy (Filed With SEC on November 12, 2020)

Lease Agreement, by and between ARE-MA Region No. 75 LLC and Forma Therapeutics, Inc., dated September 14, 2020 (Filed With SEC on November 12, 2020)

Amendment to Lease Agreement, by and between ARE-500 Arsenal Street, LLC and Forma Therapeutics, Inc. dated September 14, 2020 (Filed With SEC on November 12, 2020)

Senior Executive Cash Incentive Bonus Plan (Filed With SEC on June 15, 2020)

Form of Amended and Restated Employment Agreement (Filed With SEC on June 15, 2020)

2020 Employee Stock Purchase Plan (Filed With SEC on June 15, 2020)

Non-Employee Director Compensation Policy (Filed With SEC on June 15, 2020)

2020 Stock Option and Incentive Plan and forms of award agreements thereunder (Filed With SEC on June 15, 2020)

Form of Warrant Agreement between the Registrant and ATEL Ventures, Inc (Filed With SEC on June 15, 2020)

Form of Specimen Common Stock Certificate (Filed With SEC on June 15, 2020)

Form of Underwriting Agreement (Filed With SEC on June 15, 2020)

2019 Stock Incentive Plan and forms of award agreements thereunder (Filed With SEC on May 29, 2020)

Asset Purchase Agreement, by and between Forma Therapeutics, Inc., Integral Health, Inc. and, solely for certain Sections, Integral Health Holdings, LLC, dated March 16, 2020 (Filed With SEC on May 29, 2020)

License Agreement by and among the Registrant, Forma Therapeutics, Inc. and Celgene Alpine Investment Company II, LLC, dated December 28, 2018 (Filed With SEC on May 29, 2020)

Collaboration and License Agreement by and between Forma Therapeutics, Inc. and Boehringer Ingelheim International GmbH, dated December 21, 2011 (Filed With SEC on May 29, 2020)

Separation and Release Agreement between the Registrant and Steven Tregay, dated October 31, 2019, as revised February 25, 2020 (Filed With SEC on May 29, 2020)

Employment Agreement between the Registrant and Robert T. Sarisky, dated August 15, 2012 (Filed With SEC on May 29, 2020)

Employment Agreement between the Registrant and Steven Tregay, dated October 6, 2008, as amended June 17, 2010 (Filed With SEC on May 29, 2020)

Lease Agreement, by and between ARE-500 Arsenal Street, LLC and Forma Therapeutics, Inc., dated May 20, 2011, as amended on July 2, 2011, January 3, 2012, May 24, 2012, July 16,... (Filed With SEC on May 29, 2020)

Third Amended and Restated Investors Rights Agreement among the Registrant and certain of its stockholders, dated December 18, 2019 (Filed With SEC on May 29, 2020)

Forma Therapeutics Holdings, Inc., (28)